Posttraumatic Stress Disorder in Parents and Children After Discharge From the Pediatric Intensive Care Unit
NCT ID: NCT05186844
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1 participants
OBSERVATIONAL
2019-01-01
2020-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: This study was conducted with children who had spent time in an intensive care unit and their parents to examine the development of posttraumatic stress disorder (PTSD) in both children and parents.
Methods: The study was a cross-sectional study. A total of 110 children, 98 mothers and 80 fathers were included in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-traumatic Stress Disorder After Pediatric Intensive Care Unit Hospitalization
NCT04648605
Emotional and Social Impact on the Relatives of Hospitalized Children for Severe Trauma
NCT04168827
Validation of the Turkish Version of PTSD-RI-5
NCT06077474
Experience of Staying in Intensive Care and Impact on Quality of Life
NCT07339891
Does a Follow-up Appointment Help Parents of Children on PICU?
NCT01628263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: This study was conducted with children who had spent time in an intensive care unit and their parents to examine the development of posttraumatic stress disorder (PTSD) in both children and parents.
Methods: The research was carried out in the intensive care unit of a children's hospital in Turkey. Children between the ages of 8-12 who had spent time in the PICU over the period January 1 - March 1, 2019, who had been discharged from the PICU or transferred into another unit during this time, and who met the research criteria were included in the study. Between these dates, the total number of children discharged from intensive care or transferred into another unit was 166. Of these children, 138 were between the ages of 8-12. During this period, three children who died, two children whose general condition meant they were unable to participate in the study, and 23 children for whom parental consent could not be obtained were excluded from the study. The study was ultimately completed with 110 children. In addition, the parents of the children in the sample group (98 mothers and 80 fathers) who were alive, reachable, and who agreed to participate were included in the study.
Results: A total of 110 children, 98 mothers and 80 fathers who agreed to participate in the study, met the sample selection criteria, and were available throughout were included in the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
survey application
Scales and questionnaires were applied to children and their parents according to age groups.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child had an accompanying adult present,
* The child was conscious and/or able to communicate verbally,
* The child did not have any intellectual disability,
* There were no challenges in communicating with the family and/or the child (i.e., they spoke Turkish, were able to communicate),
* The child's stay at the PICU was no longer than 29 days,
* The child and their family volunteered to participate in the study.
8 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir Osmangazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayşegül Karaca
Nurse
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aysegul
Ankara, Mamak, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ayfer Açıkgöz
Identifier Type: OTHER
Identifier Source: secondary_id
Study1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.